21-22 mai 2026 Illkirch-Graffenstaden (France)
Synergism between Krameria lappacea root extracts and gentamicin against Gram-Positive bacteria.
Hugo Debelvalet  1@  , François Gauvain  1  , Regine Janel-Bintz  2@  , Pierre Fechter  2@  , Joelle Quetin-Leclercq  3@  , Nektarios Aligiannis  4  , Catherine Vonthron-Sénécheau  1  , Raphaël Grougnet  5  , Sabrina Boutefnouchet  5@  , Felix Galleguillos  6  , Sergio Ortiz  1@  
1 : UMR CNRS 7200 Laboratoire d'Innovation Thérapeutique
université de Strasbourg, Centre National de la Recherche Scientifique
2 : Biotechnologie et signalisation cellulaire
université de Strasbourg, Centre National de la Recherche Scientifique
3 : Louvain Drug Research Institute [Bruxelles, Belgique]
4 : Department of Pharmacognosy and Chemistry of Natural Products
5 : UMR 8038 Team Produit Naturels, Analyses et Synthèse
Université Paris Cité, Centre National de la Recherche Scientifique - CNRS
6 : Universidad Católica del Norte-Universidad de Tarapacá, San Pedro de Atacama

Over the past years, one major public health priority is to develop new antibacterial drugs due to rising resistance and few viable alternatives exist. One promising strategy is enhancing existing antibiotics through combination therapy, by pairing them with plant-derived extracts, which has gained increasing attention in recent decades [1].

Previous research demonstrated that Krameria lappacea root extracts, rich in neolignans, exhibit strong antibacterial activity, with MIC values of 0.5–2 µg/mL against Gram-positive bacteria [2]. This study explored the synergistic antibacterial potential of K. lappacea root supercritic fluid extracts combined with conventional antibiotics, building on LickanAntay traditional medicinal knowledge.

Extracts were prepared using C02 as supercritical fluid and ethanol as co-solvent with 5% (KL5), 10% (KL10), and 20% (KL20). Chemical analysis via HPLC-PDA-HRMS/MS and the GNPS platform revealed as expected a rich composition of polyphenolic compounds, including neolignans, but also methoxy-catechins, phenylethyl-hexosides, and flavonolignan derivatives, coherent with previus analyses reported for K. lappacea [3].

Notably, neolignans dominated the less polar KL5 extract, while flavonolignans and other polar compounds prevailed in the more polar KL20 extract, with nine phenolic compounds identified for the first time in this species. In vitro tests showed that the KL5/gentamicin combination exhibited synergistic effects against Bacillus spp., Listeria spp., and Staphylococcus spp., with FICI values ranging from 0.27 to 0.48. The major neolignan compound in KL5 was isolated and tested with gentamicin on Staphylococcus spp., demonstrating a slight synergistic effect with FICI values around 0.8. These findings highlight the potential of K. lappacea extracts to enhance antibiotic efficacy and combat bacterial resistance.

 

 

[1] Stefanović, O.D. Synergistic activity of antibiotics and bioactive plant extracts: a study against Gram-positive and Gram-negative bacteria. Bact. Pathog. Antibact. Control. 2017

[2] Ortiz, S., Lecsö-Bornet, M., Bonnal, C., Houze, S., Michel, S., Grougnet, R., and Boutefnouchet, S. Bioguided identification of triterpenoids and neolignans as bioactive compounds from anti-infectious medicinal plants of the Taira Atacama's community (Calama, Chile). J. Ethnopharmacol. 2019; 231, 217–229

[3] Simpson, B.B. The past and present uses of rhatany (Krameria, Krameriaceae). Econ. Bot. 1991; 45 (3), 397–409



  • Poster
Chargement... Chargement...